pyrazines has been researched along with chelerythrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Eckly-Michel, AE; Le Bec, A; Lugnier, C | 1 |
Chen, HP; He, M; Huang, QR; Liu, D; Zeng, GH | 1 |
Brewin, JN; Gibson, JS; Hannemann, A; Rees, DC; Wadud, R | 1 |
3 other study(ies) available for pyrazines and chelerythrine
Article | Year |
---|---|
Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases.
Topics: Adrenergic beta-Agonists; Alkaloids; Animals; Aorta; Benzophenanthridines; Cardiotonic Agents; Cattle; Drug Interactions; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Glycoproteins; Hydrolysis; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phenanthridines; Protein Kinase C; Pyrazines; Rats; Rats, Wistar | 1997 |
Delayed protection of tetramethylpyrazine on neonatal rat cardiomyocytes subjected to anoxia-reoxygenation injury.
Topics: Alkaloids; Animals; Benzophenanthridines; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glutathione Peroxidase; HSP70 Heat-Shock Proteins; In Vitro Techniques; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Kinase C; Pyrazines; Rats; Superoxide Dismutase; Vasodilator Agents | 2007 |
Yoda1 and phosphatidylserine exposure in red cells from patients with sickle cell anaemia.
Topics: Anemia, Sickle Cell; Benzophenanthridines; Calcium; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Humans; Intercellular Signaling Peptides and Proteins; Ion Channels; Phosphatidylserines; Protein Kinase C; Pyrazines; Spider Venoms; Thiadiazoles | 2020 |